Home » Author Archive

Sudhir Gopalswamy Sells 3,000 Shares of Cypress Semiconductor Co. (NASDAQ:CY) Stock

Cypress Semiconductor Co. (NASDAQ:CY) EVP Sudhir Gopalswamy sold 3,000 shares of the company’s stock in a transaction dated Tuesday, July 16th. The shares were sold at an average price of $22.45, for a total transaction of $67,350.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Sudhir Gopalswamy also recently made the following trade(s): On Tuesday, June 18th, Sudhir Gopalswamy sold 3,000 shares of Cypress Semiconductor stock. The shares were sold... 
 

Ariel Hurley Sells 830 Shares of Blueprint Medicines Corp (NASDAQ:BPMC) Stock

Blueprint Medicines Corp (NASDAQ:BPMC) insider Ariel Hurley sold 830 shares of the company’s stock in a transaction dated Monday, July 15th. The shares were sold at an average price of $94.98, for a total value of $78,833.40. Following the completion of the sale, the insider now owns 830 shares in the company, valued at approximately $78,833.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Ariel Hurley also recently made the following trade(s): On Monday, June 17th, Ariel Hurley sold... 
 

Okta (NASDAQ:OKTA) Price Target Raised to $154.00 at Needham & Company LLC

Okta (NASDAQ:OKTA) had its price target lifted by analysts at Needham & Company LLC to $154.00 in a report issued on Wednesday, The Fly reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price suggests a potential upside of 11.06% from the company’s current price. A number of other equities research analysts have also weighed in on OKTA. Deutsche Bank restated a “buy” rating and issued a GBX 430 ($5.62) target price on shares of in a report on Friday, June... 
 

Zacks Investment Research Upgrades Pennsylvania R.E.I.T. (NYSE:PEI) to Buy

Pennsylvania R.E.I.T. (NYSE:PEI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday, Zacks.com reports. The firm currently has a $7.25 target price on the real estate investment trust’s stock. Zacks Investment Research‘s price objective would suggest a potential upside of 16.19% from the company’s current price. According to Zacks, “PENNSYLVANIA R.E. INVEST. TR. is a real estate investment trust, engaged in acquiring and holding... 
 

Wix.Com (NASDAQ:WIX) Stock Rating Reaffirmed by Wedbush

Wix.Com (NASDAQ:WIX)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a report released on Wednesday, RTT News reports. They presently have a $152.00 target price on the information services provider’s stock. Wedbush’s price objective indicates a potential upside of 6.22% from the stock’s previous close. A number of other brokerages have also recently commented on WIX. Citigroup set a $8.00 target price on shares of Diamond Offshore Drilling and gave the company a “sell”... 
 

Columbia Sportswear (NASDAQ:COLM) Given Outperform Rating at Wedbush

Columbia Sportswear (NASDAQ:COLM)‘s stock had its “outperform” rating reiterated by equities research analysts at Wedbush in a report released on Wednesday, RTT News reports. They presently have a $118.00 target price on the textile maker’s stock. Wedbush’s price objective indicates a potential upside of 13.30% from the stock’s current price. Wedbush also issued estimates for Columbia Sportswear’s Q2 2019 earnings at $0.01 EPS, FY2019 earnings at $4.58 EPS and FY2020 earnings at $5.04 EPS. A number of other... 
 

Osisko gold royalties (NYSE:OR) Upgraded by Zacks Investment Research to Hold

Osisko gold royalties (NYSE:OR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Osisko Gold Ltd is a mining company which is engaged in exploration and mining for gold and other precious metals. Osisko Gold Ltd is headquartered in Montreal, Canada. “ OR has been the subject of several other reports. National Bank Financial lowered Calfrac Well Services from an “outperform market weight”... 
 

CSX (NASDAQ:CSX) Price Target Cut to $75.00 by Analysts at Royal Bank of Canada

CSX (NASDAQ:CSX) had its target price dropped by research analysts at Royal Bank of Canada to $75.00 in a research note issued on Wednesday, The Fly reports. The brokerage currently has a “sector perform” rating on the transportation company’s stock. Royal Bank of Canada’s price objective points to a potential upside of 4.41% from the company’s previous close. A number of other research firms have also weighed in on CSX. UBS Group restated a “buy” rating on shares of Cie Gnrl des Etblsmnts Michelin SCA... 
 

Omeros (NASDAQ:OMER) Downgraded by Zacks Investment Research

Omeros (NASDAQ:OMER) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros’ most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed... 
 

Pebblebrook Hotel Trust (NYSE:PEB) Cut to “Sell” at Zacks Investment Research

Pebblebrook Hotel Trust (NYSE:PEB) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Pebblebrook Hotel Trust is an internally managed hotel investment company organized to acquire and invest in hotel properties located primarily in large United States cities with an emphasis on the major coastal markets. The Company may invest in resort properties located near its primary urban target markets, as well... 
 

Potlatchdeltic (NASDAQ:PCH) Downgraded by Zacks Investment Research

Potlatchdeltic (NASDAQ:PCH) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Potlatch Corporation is a Real Estate Investment Trust (REIT) with the acres of timberland in Alabama, Arkansas, Idaho, Minnesota and Mississippi. Potlatch, a certified forest practices leader, is committed to providing superior returns to stockholders through long-term stewardship of its forest resources.... 
 

ExlService (NASDAQ:EXLS) Receives “Buy” Rating from Barrington Research

ExlService (NASDAQ:EXLS)‘s stock had its “buy” rating reiterated by Barrington Research in a report issued on Wednesday, AnalystRatings.com reports. The analysts wrote, “We expect EXL to report Q2/19 non-GAAP EPS of $0.71, which is in line with the FactSet consensus of $0.71. Our expectation represents year-over-year growth of 6% and a sequentially flat result.”” Several other analysts also recently issued reports on EXLS. Cantor Fitzgerald reiterated a “buy” rating and set a $71.00 price target... 
 

HSBC (NYSE:HSBC) Lowered to Underweight at Barclays

HSBC (NYSE:HSBC) was downgraded by stock analysts at Barclays from an “equal weight” rating to an “underweight” rating in a research note issued on Wednesday, Marketbeat Ratings reports. A number of other analysts have also recently commented on the stock. Morgan Stanley reaffirmed a “hold” rating on shares of PG&E in a research report on Friday, June 21st. ValuEngine cut shares of Zuora from a “buy” rating to a “hold” rating in a research report on Saturday, June 1st. Finally, Goldman... 
 

CooTek (Cayman) (NYSE:CTK) Stock Rating Lowered by Bank of America

CooTek (Cayman) (NYSE:CTK) was downgraded by research analysts at Bank of America from a “buy” rating to an “underperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports. A number of other equities analysts have also weighed in on CTK. Credit Suisse Group restated an “outperform” rating and set a GBX 3,175 ($41.49) target price on shares of in a research report on Tuesday, June 4th. Zacks Investment Research upgraded shares of Flagstar Bancorp from a “hold”... 
 

Onconova Therapeutics (NASDAQ:ONTX) Upgraded to Hold at Zacks Investment Research

Onconova Therapeutics (NASDAQ:ONTX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company’s products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV, ON 013105 and Recilisib.... 
 

PDF Solutions (NASDAQ:PDFS) Raised to Buy at Zacks Investment Research

PDF Solutions (NASDAQ:PDFS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The firm presently has a $14.00 target price on the technology company’s stock. Zacks Investment Research‘s price target indicates a potential upside of 8.11% from the company’s previous close. According to Zacks, “PDF Solutions, Inc.’s comprehensive technologies and services enable semiconductor companies to improve yield and... 
 

Uwe Schramm Sells 2,000 Shares of Altair Engineering Inc (NASDAQ:ALTR) Stock

Altair Engineering Inc (NASDAQ:ALTR) insider Uwe Schramm sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $41.14, for a total transaction of $82,280.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Uwe Schramm also recently made the following trade(s): On Monday, July 1st, Uwe Schramm sold 2,000 shares of Altair Engineering stock. The stock was sold at an average price of $40.92, for a total transaction... 
 

Otonomy (NASDAQ:OTIC) Rating Increased to Buy at Zacks Investment Research

Otonomy (NASDAQ:OTIC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The brokerage currently has a $2.75 target price on the biopharmaceutical company’s stock. Zacks Investment Research‘s target price points to a potential upside of 9.56% from the stock’s current price. According to Zacks, “Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It... 
 

Mizuho Reaffirms “Buy” Rating for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ:VRAY)‘s stock had its “buy” rating restated by investment analysts at Mizuho in a research note issued to investors on Wednesday, AnalystRatings.com reports. They currently have a $12.00 price objective on the stock. Mizuho’s price target would indicate a potential upside of 30.15% from the stock’s current price. Several other research analysts also recently commented on the stock. BidaskClub downgraded shares of Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in... 
 

Office Properties Income Trust (NASDAQ:OPI) Stock Rating Lowered by Zacks Investment Research

Office Properties Income Trust (NASDAQ:OPI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Office Properties Income Trust is a real estate investment trust. It owns buildings primarily leased to single tenants as well as government entities. Office Properties Income Trust, formerly known as Government Properties Income Trust, is based in Newton, United States. “ A number of other brokerages... 
 

Whirlpool (NYSE:WHR) PT Raised to $150.00 at Buckingham Research

Whirlpool (NYSE:WHR) had its price objective upped by analysts at Buckingham Research from $135.00 to $150.00 in a note issued to investors on Wednesday, The Fly reports. The brokerage currently has a “neutral” rating on the stock. Buckingham Research’s price target indicates a potential downside of 0.25% from the company’s previous close. Several other equities analysts have also recently weighed in on the stock. ValuEngine upgraded shares of China Southern Airlines from a “sell” rating to a “hold”... 
 

Apple (NASDAQ:AAPL) PT Raised to $187.00 at Goldman Sachs Group

Apple (NASDAQ:AAPL) had its price objective raised by investment analysts at Goldman Sachs Group from $171.00 to $187.00 in a research report issued on Wednesday, Marketbeat.com reports. The firm currently has a “neutral” rating on the iPhone maker’s stock. Goldman Sachs Group’s price target would indicate a potential downside of 9.07% from the stock’s previous close. Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. began coverage on Pinduoduo in a research note... 
 

Experian (LON:EXPN) Price Target Raised to GBX 2,600

Experian (LON:EXPN) had its price objective raised by investment analysts at JPMorgan Chase & Co. from GBX 2,400 ($31.36) to GBX 2,600 ($33.97) in a report issued on Wednesday, Digital Look reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 7.66% from the company’s previous close. Other research analysts have also recently issued research reports about the stock. Credit Suisse Group cut shares of to a “neutral”... 
 

Vipshop (NYSE:VIPS) Given Neutral Rating at Credit Suisse Group

Vipshop (NYSE:VIPS)‘s stock had its “neutral” rating restated by stock analysts at Credit Suisse Group in a research report issued on Wednesday, Briefing.com Automated Import reports. Several other equities analysts have also issued reports on the company. Daiwa Capital Markets upgraded Vipshop from an “underperform” rating to a “neutral” rating in a research report on Friday, May 24th. KeyCorp increased their price target on Vipshop from $10.00 to $11.00 and gave the company an “overweight”... 
 

Park Hotels & Resorts (NYSE:PK) Downgraded by Zacks Investment Research

Park Hotels & Resorts (NYSE:PK) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Park Hotels & Resorts Inc. is a lodging Real Estate Company. The company operates luxury hotels and resorts in USA and international market. Park Hotels & Resorts Inc. is based in Mc Lean, Virginia. “ PK has been the subject of several other research reports. Capital One Financial initiated coverage on... 
 

Photronics (NASDAQ:PLAB) Raised to Buy at Zacks Investment Research

Photronics (NASDAQ:PLAB) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The firm presently has a $9.25 price target on the semiconductor company’s stock. Zacks Investment Research‘s price target indicates a potential upside of 5.35% from the company’s previous close. According to Zacks, “Photronics is a leading worldwide manufacturer of photomasks. Photomasks are high precision quartz plates that contain... 
 

CNOOC (NYSE:CEO) Lowered to Neutral at Daiwa Capital Markets

CNOOC (NYSE:CEO) was downgraded by research analysts at Daiwa Capital Markets from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, Marketbeat reports. Several other research firms also recently issued reports on CEO. UBS Group set a $169.00 price objective on shares of M&T Bank and gave the stock a “hold” rating in a report on Tuesday, April 2nd. JPMorgan Chase & Co. set a $195.00 price objective on shares of bluebird bio and gave the stock a “buy” rating in... 
 

Hancock Whitney (NYSE:HWC) Receives “Hold” Rating from Stephens

Hancock Whitney (NYSE:HWC)‘s stock had its “hold” rating reissued by analysts at Stephens in a note issued to investors on Wednesday, AnalystRatings.com reports. They presently have a $42.00 price target on the stock. Stephens’ price target indicates a potential upside of 4.48% from the company’s previous close. A number of other research firms also recently issued reports on HWC. Zacks Investment Research upgraded GreenTree Hospitality Group from a “sell” rating to a “hold” rating in a research... 
 

Baidu’s (BIDU) “Outperform” Rating Reaffirmed at Credit Suisse Group

Baidu (NASDAQ:BIDU)‘s stock had its “outperform” rating reaffirmed by equities researchers at Credit Suisse Group in a report released on Wednesday, Briefing.com Automated Import reports. BIDU has been the topic of a number of other research reports. ValuEngine lowered Zymeworks from a “buy” rating to a “hold” rating in a research report on Saturday, May 18th. China Renaissance Securities reissued a “hold” rating on shares of Baidu in a research report on Monday, April 15th. Mizuho boosted their... 
 

Royal Bank of Canada Raises Cintas (NASDAQ:CTAS) Price Target to $267.00

Cintas (NASDAQ:CTAS) had its price objective lifted by investment analysts at Royal Bank of Canada to $267.00 in a research report issued on Wednesday, The Fly reports. The firm presently has an “outperform” rating on the business services provider’s stock. Royal Bank of Canada’s target price points to a potential upside of 2.44% from the company’s current price. Several other equities analysts also recently commented on CTAS. Zacks Investment Research downgraded G1 Therapeutics from a “buy” rating to a... 
 

Baozun (NASDAQ:BZUN) Stock Rating Reaffirmed by Credit Suisse Group

Baozun (NASDAQ:BZUN)‘s stock had its “outperform” rating reaffirmed by analysts at Credit Suisse Group in a research report issued to clients and investors on Wednesday, Briefing.com Automated Import reports. A number of other research firms also recently commented on BZUN. BidaskClub downgraded Waterstone Financial from a “hold” rating to a “sell” rating in a research note on Friday, June 21st. ValuEngine raised Zuora from a “hold” rating to a “buy” rating in a research note on Saturday,... 
 

Pennantpark Floating Rate Capital (NASDAQ:PFLT) Lowered to “Hold” at Zacks Investment Research

Pennantpark Floating Rate Capital (NASDAQ:PFLT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “PennantPark Floating Rate Capital Ltd. is a business development company. It is a closed-end, externally managed and non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing primarily in floating rate loans and other investments made to the... 
 

PetroChina (NYSE:PTR) Rating Increased to Outperform at Macquarie

PetroChina (NYSE:PTR) was upgraded by investment analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. Several other research analysts have also recently issued reports on the company. Citigroup set a $27.00 target price on PhaseBio Pharmaceuticals and gave the stock a “buy” rating in a research report on Friday, May 24th. Daiwa Capital Markets initiated coverage on PetroChina in a research report... 
 

Tesla (NASDAQ:TSLA) Stock Rating Reaffirmed by Morgan Stanley

Tesla (NASDAQ:TSLA)‘s stock had its “neutral” rating reissued by stock analysts at Morgan Stanley in a note issued to investors on Wednesday, Borsen Zeitung reports. They presently have a $230.00 target price on the electric vehicle producer’s stock. Morgan Stanley’s price objective indicates a potential downside of 9.28% from the stock’s previous close. A number of other equities analysts also recently commented on TSLA. Wolfe Research downgraded Tesla from an “outperform” rating to a “market... 
 

Symrise (FRA:SY1) Given a €89.00 Price Target by Warburg Research Analysts

Symrise (FRA:SY1) has been assigned a €89.00 ($103.49) target price by equities research analysts at Warburg Research in a report issued on Wednesday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. Warburg Research’s price target suggests a potential upside of 6.95% from the company’s current price. Several other equities research analysts also recently commented on the stock. Barclays reaffirmed a “hold” rating and set a $52.00 price objective on shares of Biohaven Pharmaceutical... 
 

Turquoise Hill Resources (NYSE:TRQ) Cut to Neutral at CIBC

Turquoise Hill Resources (NYSE:TRQ) (TSE:TRQ) was downgraded by equities research analysts at CIBC from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, The Fly reports. A number of other brokerages have also recently issued reports on TRQ. ValuEngine cut shares of Zogenix from a “strong-buy” rating to a “buy” rating in a research note on Thursday, April 11th. Eight Capital cut shares of Turquoise Hill Resources from a “buy” rating to a “neutral”... 
 

Pointer Telocation (NASDAQ:PNTR) Cut to Hold at Zacks Investment Research

Pointer Telocation (NASDAQ:PNTR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Pointer Telocation Ltd provides range of services to insurance companies and automobile owners, including road-side assistance, vehicle towing, stolen vehicle retrieval, fleet management and other value added services. Pointer Telocation provides services, for the most part, in Israel, through its subsidiary Shagrir and... 
 

JD.Com’s (JD) “Outperform” Rating Reaffirmed at Credit Suisse Group

JD.Com (NASDAQ:JD)‘s stock had its “outperform” rating reiterated by Credit Suisse Group in a research report issued to clients and investors on Wednesday, Briefing.com Automated Import reports. A number of other brokerages have also recently issued reports on JD. JPMorgan Chase & Co. increased their price objective on shares of Weight Watchers International from $12.00 to $14.00 and gave the company an “underweight” rating in a research note on Tuesday, April 30th. Loop Capital started coverage on shares of TENCENT... 
 

Commerce Bancshares (NASDAQ:CBSH) PT Raised to $62.00 at DA Davidson

Commerce Bancshares (NASDAQ:CBSH) had its price objective lifted by equities researchers at DA Davidson to $62.00 in a report issued on Wednesday, The Fly reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. DA Davidson’s price objective indicates a potential upside of 6.29% from the company’s current price. CBSH has been the subject of several other reports. Zacks Investment Research raised Eutelsat Communications from a “hold” rating to a “strong-buy”... 
 

Sogou’s (SOGO) “Neutral” Rating Reaffirmed at Credit Suisse Group

Sogou (NYSE:SOGO)‘s stock had its “neutral” rating reissued by investment analysts at Credit Suisse Group in a report issued on Wednesday, Briefing.com Automated Import reports. Other analysts have also recently issued research reports about the stock. Bank of America initiated coverage on shares of Sogou in a report on Monday, April 1st. They issued an “underperform” rating and a $5.60 price objective on the stock. JPMorgan Chase & Co. cut shares of Sogou from a “neutral” rating to an “underweight”... 
 

PennyMac Financial Services (NYSE:PFSI) Upgraded to “Strong-Buy” at Zacks Investment Research

PennyMac Financial Services (NYSE:PFSI) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage currently has a $26.00 target price on the real estate investment trust’s stock. Zacks Investment Research‘s target price would suggest a potential upside of 9.01% from the company’s previous close. According to Zacks, “PennyMac Financial Services, Inc. provides financial services primarily... 
 

Leo I. Higdon, Jr. Sells 4,883 Shares of Eaton Vance Corp (NYSE:EV) Stock

Eaton Vance Corp (NYSE:EV) Director Leo I. Higdon, Jr. sold 4,883 shares of Eaton Vance stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $44.32, for a total transaction of $216,414.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Shares of EV opened at $44.37 on Friday. The company has a quick ratio of 11.82, a current ratio of 11.82 and a debt-to-equity ratio of 1.49. The firm has a market cap of $4.97 billion, a... 
 

Richard Buchholz Sells 4,000 Shares of Inspire Medical Systems (NASDAQ:INSP) Stock

Inspire Medical Systems (NASDAQ:INSP) CFO Richard Buchholz sold 4,000 shares of the stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $68.34, for a total value of $273,360.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Richard Buchholz also recently made the following trade(s): On Monday, June 17th, Richard Buchholz sold 4,000 shares of Inspire Medical Systems stock. The shares were sold at an average price of $56.37, for a total... 
 

John S. Quinn Sells 10,721 Shares of LKQ Co. (NASDAQ:LKQ) Stock

LKQ Co. (NASDAQ:LKQ) EVP John S. Quinn sold 10,721 shares of the company’s stock in a transaction on Monday, July 15th. The stock was sold at an average price of $27.04, for a total transaction of $289,895.84. Following the completion of the transaction, the executive vice president now owns 254,674 shares of the company’s stock, valued at $6,886,384.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. LKQ stock opened at $25.68 on Friday. The company has... 
 

David A. Ottewell Sells 38,385 Shares of NovaGold Resources Inc. (NYSEAMERICAN:NG) Stock

NovaGold Resources Inc. (NYSEAMERICAN:NG) (TSE:NG) VP David A. Ottewell sold 38,385 shares of the firm’s stock in a transaction on Tuesday, July 16th. The stock was sold at an average price of $6.24, for a total value of $239,522.40. Following the transaction, the vice president now directly owns 662,265 shares of the company’s stock, valued at $4,132,533.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Shares of NYSEAMERICAN:NG opened at $6.53 on Friday. NovaGold Resources Inc.... 
 

Michael Thomas Heffernan Sells 25,000 Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) Stock

Collegium Pharmaceutical Inc (NASDAQ:COLL) Director Michael Thomas Heffernan sold 25,000 shares of the company’s stock in a transaction on Monday, July 15th. The stock was sold at an average price of $11.26, for a total transaction of $281,500.00. Following the sale, the director now directly owns 132,069 shares of the company’s stock, valued at approximately $1,487,096.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Michael Thomas Heffernan also recently... 
 

A.G. Barr (LON:BAG) PT Lowered to GBX 590

A.G. Barr (LON:BAG) had its price target decreased by investment analysts at Barclays from GBX 720 ($9.41) to GBX 590 ($7.71) in a report issued on Wednesday, Digital Look reports. The firm presently has an “underweight” rating on the stock. Barclays‘s target price would indicate a potential downside of 4.19% from the stock’s previous close. Several other equities analysts have also recently issued reports on BAG. HSBC set a $46.00 price objective on Aqua America and gave the stock a “buy” rating in a research... 
 

Lennox International (NYSE:LII) Given New $276.00 Price Target at Buckingham Research

Lennox International (NYSE:LII) had its price target boosted by equities researchers at Buckingham Research from $273.00 to $276.00 in a research report issued to clients and investors on Wednesday, BenzingaRatingsTable reports. The brokerage currently has a “neutral” rating on the construction company’s stock. Buckingham Research’s price target points to a potential downside of 2.80% from the stock’s previous close. LII has been the subject of a number of other research reports. JPMorgan Chase & Co. upgraded shares... 
 

RCI Hospitality (NASDAQ:RICK) Downgraded by Zacks Investment Research to Sell

RCI Hospitality (NASDAQ:RICK) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “RCI Hospitality Holdings, Inc. owns and/or operates adult nightclubs that offer live adult entertainment, restaurant, and bar services. It operates adult nightclubs under the name Rick’s Cabaret, Club Onyx, XTC Cabaret, Tootsie’s Cabaret, Cabaret North, Jaguars and Cabaret East. The Company also owns and operates... 
 

Ritter Pharmaceuticals (NASDAQ:RTTR) Rating Lowered to Hold at Zacks Investment Research

Ritter Pharmaceuticals (NASDAQ:RTTR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. Ritter Pharmaceuticals,... 
 
© 2006-2019 Ticker Report